Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joanne Kavanagh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Breathe (Sheffield, England)|April 30, 2019
Over- and under-diagnosis in asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Current Opinion in Pulmonary Medicine|September 11, 2018
Sleep and asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Pulmonary Pharmacology & Therapeutics|February 15, 2015
Adult and paediatric cough guidelines: Ready for an overhaul?Surinder S Birring, Joanne Kavanagh, Kefang Lai, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
ERJ Open Research|January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitisBrian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
ERJ Open Research|December 2, 2020
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitisAlexandra M Nanzer, Jaideep Dhariwal, Joanne Kavanagh, et al.
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Breathe (Sheffield, England)|April 30, 2019
Over- and under-diagnosis in asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Current Opinion in Pulmonary Medicine|September 11, 2018
Sleep and asthmaJoanne Kavanagh, David J Jackson, Brian D Kent
Pulmonary Pharmacology & Therapeutics|February 15, 2015
Adult and paediatric cough guidelines: Ready for an overhaul?Surinder S Birring, Joanne Kavanagh, Kefang Lai, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
ERJ Open Research|January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitisBrian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
ERJ Open Research|December 2, 2020
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitisAlexandra M Nanzer, Jaideep Dhariwal, Joanne Kavanagh, et al.
The European Respiratory Journal|February 26, 2021
Real world effectiveness of anti-IL-5/5R therapies is independent of co-eligibility for anti-IgE therapyAndrew P Hearn, Oliver D Hug, Ziana A Somani, et al.
Pageof 1